Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum

The impact of quality assurance assessment on diffusion tensor imaging outcomes in a large-scale population-based cohort

(2016) David R. Roalf et al.   NEUROIMAGE

In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease

(2016) Jérémy Pépin et al.   NEUROIMAGE

Altered Glutamate and Regional Cerebral Blood Flow Levels in Schizophrenia: A 1H-MRS and pCASL study

(2016) S Andrea Wijtenburg et al.   NEUROPSYCHOPHARMACOLOGY

Are there glutamate abnormalities in subjects at high risk mental state for psychosis? A review of the evidence

(2016) Devi Treen et al.   SCHIZOPHRENIA RESEARCH

Nature of Glutamate Alterations in Schizophrenia

(2016) Kate Merritt et al.   JAMA Psychiatry

Structural Brain Abnormalities in Youth With Psychosis Spectrum Symptoms

(2016) Theodore D. Satterthwaite et al.   JAMA Psychiatry

Heritability of Subcortical and Limbic Brain Volume and Shape in Multiplex-Multigenerational Families with Schizophrenia

(2015) David R. Roalf et al.   BIOLOGICAL PSYCHIATRY

Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe

(2015) James Stone et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium

(2015) T G M van Erp et al.   MOLECULAR PSYCHIATRY

White matter microstructure in schizophrenia: Associations to neurocognition and clinical symptomatology

(2015) David R. Roalf et al.   SCHIZOPHRENIA RESEARCH

Glutamate imaging (GluCEST) lateralizes epileptic foci in nonlesional temporal lobe epilepsy

(2015) Kathryn Adamiak Davis et al.   Science Translational Medicine

A Neurodevelopmental Perspective on the Research Domain Criteria (RDoC) Framework

(2014) B.J. Casey et al.   BIOLOGICAL PSYCHIATRY

In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy

(2014) Rachelle Crescenzi et al.   NEUROIMAGE

Relationship Between Brain Glutamate Levels and Clinical Outcome in Individuals at Ultra High Risk of Psychosis

(2014) Alice Egerton et al.   NEUROPSYCHOPHARMACOLOGY

Functional Outcome in People at High Risk for Psychosis Predicted by Thalamic Glutamate Levels and Prefronto-Striatal Activation

(2014) P. Allen et al.   SCHIZOPHRENIA BULLETIN

Imaging glutamate in schizophrenia: review of findings and implications for drug discovery

(2013) E M P Poels et al.   MOLECULAR PSYCHIATRY

Imaging of glutamate in the spinal cord using GluCEST

(2013) Feliks Kogan et al.   NEUROIMAGE

Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver

(2013) Scott A. Schobel et al.   NEURON

Mapping glutamate in subcortical brain structures using high-resolution GluCEST MRI

(2013) Kejia Cai et al.   NMR IN BIOMEDICINE

Reduced Frontal Glutamate + Glutamine and N-Acetylaspartate Levels in Patients With Chronic Schizophrenia but not in Those at Clinical High Risk for Psychosis or With First-Episode Schizophrenia

(2013) Tatsunobu Natsubori et al.   SCHIZOPHRENIA BULLETIN

Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy

(2013) Neeraj Tandon et al.   SCHIZOPHRENIA RESEARCH

Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis

(2013) Camilo de la Fuente-Sandoval et al.   JAMA Psychiatry

Predicting Psychosis

(2012) Paolo Fusar-Poli   ARCHIVES OF GENERAL PSYCHIATRY

Elevated Prefrontal Cortex γ-Aminobutyric Acid and Glutamate-Glutamine Levels in Schizophrenia Measured In Vivo With Proton Magnetic Resonance Spectroscopy

(2012) Xiangling Mao   ARCHIVES OF GENERAL PSYCHIATRY

Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study

(2012) Camilo de la Fuente-Sandoval et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Neurodevelopmental model of schizophrenia: update 2012

(2012) J L Rapoport et al.   MOLECULAR PSYCHIATRY

Magnetic resonance imaging of glutamate

(2012) Kejia Cai et al.   NATURE MEDICINE

Imaging of glutamate neurotransmitter alterations in Alzheimer's disease

(2012) Mohammad Haris et al.   NMR IN BIOMEDICINE

Resting-state glutamate level in the anterior cingulate predicts blood-oxygen level-dependent response to cognitive control

(2012) L. E. Falkenberg et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Thalamic Glutamate Levels as a Predictor of Cortical Response During Executive Functioning in Subjects at High Risk for Psychosis

(2011) P. Fusar-Poli   ARCHIVES OF GENERAL PSYCHIATRY

Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment

(2011) Gary Remington et al.   Expert Review of Neurotherapeutics

1H-MR spectroscopy in ultra-high risk and first episode stages of schizophrenia

(2011) Idun Uhl et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Chemical exchange saturation transfer (CEST): What is in a name and what isn't?

(2011) Peter C. M. van Zijl et al.   MAGNETIC RESONANCE IN MEDICINE

Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis

(2011) Camilo de la Fuente-Sandoval et al.   NEUROPSYCHOPHARMACOLOGY

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

(2011) Bita Moghaddam et al.   NEUROPSYCHOPHARMACOLOGY

Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies

(2011) Anouk Marsman et al.   SCHIZOPHRENIA BULLETIN

Neuroanatomical abnormalities in schizophrenia: A multimodal voxelwise meta-analysis and meta-regression analysis

(2011) Emre Bora et al.   SCHIZOPHRENIA RESEARCH

Proton Magnetic Resonance Spectroscopy and Illness Stage in Schizophrenia—A Systematic Review and Meta-Analysis

(2010) Stefan Brugger et al.   BIOLOGICAL PSYCHIATRY

Rethinking schizophrenia

(2010) Thomas R. Insel   NATURE

White Matter Integrity and Prediction of Social and Role Functioning in Subjects at Ultra-High Risk for Psychosis

(2009) Katherine H. Karlsgodt et al.   BIOLOGICAL PSYCHIATRY

Glutamate Dysfunction in People with Prodromal Symptoms of Psychosis: Relationship to Gray Matter Volume

(2009) James M. Stone et al.   BIOLOGICAL PSYCHIATRY

The functional neuroanatomy of symptom dimensions in schizophrenia: A qualitative and quantitative review of a persistent question

(2009) Vina M. Goghari et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: Investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus

(2009) So Young Yoo et al.   SCHIZOPHRENIA RESEARCH

Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: A 1H spectroscopy study

(2009) Matcheri S. Keshavan et al.   SCHIZOPHRENIA RESEARCH

Chemical Exchange Saturation Transfer Contrast Agents for Magnetic Resonance Imaging

(2008) A. Dean Sherry et al.   Annual Review of Biomedical Engineering

Prediction of Psychosis in Youth at High Clinical Risk

(2008) Tyrone D. Cannon et al.   ARCHIVES OF GENERAL PSYCHIATRY

Meta-Analysis of Gray Matter Anomalies in Schizophrenia: Application of Anatomic Likelihood Estimation and Network Analysis

(2008) David C. Glahn et al.   BIOLOGICAL PSYCHIATRY

Elevated 3T proton MRS glutamate levels associated with poor Continuous Performance Test (CPT-0X) scores and genetic risk for schizophrenia

(2008) Scot E. Purdon et al.   SCHIZOPHRENIA RESEARCH